Give Canadian Cancer Patients Access to Evidence-Based Photobiomodulation Therapy

79

Let’s get to 100 signatures!
Petitions with 1,000+ supporters are 5x more likely to win!

The Issue

I never imagined that while fighting to save my child's life, I would also find myself fighting for access to technology that could help reduce the suffering caused by cancer treatment.

But here I am.

My son has high-risk neuroblastoma. He has already endured chemotherapy, surgery and more than most children should ever have to experience. He is now facing another extremely intensive stage of treatment involving high-dose chemotherapy and stem-cell transplantation.

As his mother, I have spent countless hours researching what lies ahead. I have spoken with families who have watched their children go through transplant. I have heard about the mouth sores, the inability to swallow, the vomiting, the diarrhea, the agonizing pain, the morphine, the feeding support and the complications that can make an already terrifying experience even worse.

And I cannot stop thinking about how much of this suffering we may be able to prevent.

I want people to understand what mucositis actually does to a person.

Mucositis is damage and inflammation to the protective lining of the body caused by cancer treatments such as chemotherapy and radiation. It can affect the mouth, tongue, throat and esophagus, and can extend throughout the gastrointestinal tract.

It can start with redness, burning, tenderness and small sores. It can progress to widespread ulceration, severe swelling, bleeding and excruciating pain.

Imagine a child who is hungry and thirsty but cannot swallow a sip of water without crying. Imagine painful ulcers covering their mouth and throat, saliva becoming difficult to swallow, and even speaking becoming unbearable.

For some patients, the damage extends further.

Gastrointestinal mucositis can cause severe abdominal cramping, nausea, vomiting and debilitating diarrhea. Patients may pass mucus with their bowel movements, experience intestinal inflammation and ulceration, and sometimes suffer gastrointestinal bleeding. Inflammation can also affect the rectal and anal tissues, making bowel movements extremely painful.

Some patients become unable to eat or drink adequately. They may require feeding tubes, intravenous fluids or total parenteral nutrition delivered through a central line. Severe pain can require powerful opioid medications, including morphine.

And the danger does not end with the pain.

The damaged protective lining of the digestive tract can allow bacteria to enter the body. For patients whose immune systems have been severely suppressed by chemotherapy, this can contribute to serious infections and potentially life-threatening complications.

Not everyone experiences every symptom, and severity varies. But for those who experience severe mucositis, the physical and emotional toll can be enormous.

THIS IS NOT A RARE PROBLEM.

Clinical guidance estimates that:

20–40% of children receiving conventional chemotherapy develop mucositis.
At least 80% of children receiving high-dose chemotherapy as preparation for stem-cell transplantation develop mucositis.
Nearly all patients receiving radiation to the head and neck experience oral mucositis.
A large multicentre study of 1,841 stem-cell transplant patients found that 71% developed oral mucositis, with 21.6% experiencing severe oral mucositis.

And this is not just about children.

Adults, teenagers and older people undergoing cancer treatment experience this too. Parents, grandparents, young adults and children can all find themselves facing the same devastating complication.

Cancer does not discriminate by age. Neither does mucositis.

BUT THERE IS TECHNOLOGY THAT CAN HELP.

It is called photobiomodulation (PBM), also known as low-level light or laser therapy.

And I am not talking about an ordinary red-light lamp, a wellness device or an unproven internet trend.

I am talking about medical photobiomodulation delivered using specific wavelengths, carefully measured doses and established clinical protocols.

One company producing medical PBM technology is THOR Photomedicine.

THOR's LX2.3 system is specifically indicated for oral mucositis in markets where it has the relevant authorization. Its technology uses carefully controlled light to interact with tissue and support biological processes involved in inflammation and healing.

There is meaningful clinical research behind this approach.

The 2021 international pediatric clinical practice guideline reviewed 107 studies, including 29 randomized controlled trials evaluating photobiomodulation. Its analysis found a risk ratio of 0.40 for severe oral mucositis among patients receiving PBM compared with controls. That represents an approximately 60% relative reduction in risk in the pooled trial results.

The guideline recommends intraoral PBM for children undergoing autologous or allogeneic stem-cell transplantation.

International MASCC/ISOO guidelines also recommend specific intraoral PBM protocols for adults undergoing high-dose chemotherapy before stem-cell transplantation and for certain head and neck cancer treatments.

These are clinical recommendations, not simply promises made by a manufacturer.

SO WHY ARE WE FIGHTING TO ACCESS THIS IN CANADA?

This is where my frustration has turned into advocacy.

I have contacted THOR Photomedicine, researched the available clinical evidence and approached healthcare decision-makers.

I have also spoken with my child's medical team about accessing this technology. I was told that funding is available, but that Health Canada's regulatory approval requirements are preventing the hospital from purchasing the equipment.

I am working to establish the exact regulatory status and outstanding requirements directly with the manufacturer and Health Canada. But regardless of the precise administrative barrier, Canadian families deserve clear answers.

If a medical device has evidence supporting its use, if clinicians want to consider it, and if funding is available, why are we not doing everything possible to resolve the barriers to access?

I am not asking Canada to ignore safety standards. I am not asking for every red-light device to be approved. I am asking for the timely, transparent assessment of medical photobiomodulation technology and a serious effort to make clinically appropriate treatment available.

I should not have to spend my child's cancer journey trying to navigate medical-device regulation to find supportive care.

Neither should any other parent.

WHAT WE ARE ASKING FOR

We are calling on the Government of Canada, Health Canada and healthcare decision-makers to:

Provide clear information about the Canadian regulatory status of THOR Photomedicine's medical PBM systems and the requirements for their use in mucositis prevention and treatment.
Ensure timely and transparent review of any outstanding medical-device licensing applications.
Work directly with THOR Photomedicine and other relevant manufacturers to identify and resolve regulatory barriers.
Work with Canadian hospitals and provincial and territorial health authorities to make clinically appropriate PBM treatment available.
Support equitable access to evidence-based photobiomodulation for cancer patients of all ages.
I AM ASKING YOU TO HELP ME CHANGE THIS.

I am one mother. I cannot change Canada's medical-device regulations on my own. But together, we can make this an issue that cannot be ignored.

If your child has experienced mucositis, I want to hear your story.

If you have experienced it as an adult, I want to hear your story.

If you have watched someone you love suffer through it, I want to hear your story.

If you have received photobiomodulation treatment, particularly through THOR, I want to hear about your experience.

If you are a healthcare professional, researcher or someone working in oncology, your voice matters too.

Please share your experiences in the comments. Tell us what happened, what helped, what didn't, and whether you were offered access to PBM.

These experiences matter. They help other families feel less alone, help people understand the reality of mucositis and strengthen the case for better access to supportive care.

Children deserve better. Adults deserve better. Families deserve better.

We cannot promise to eliminate every complication of cancer treatment. But when there are evidence-supported options that may reduce suffering, we should not accept unnecessary barriers preventing patients from accessing them.

Better exists. Let's fight to make it accessible in Canada.

Please sign. Please share. Please add your story.

Let's make a difference.

avatar of the starter
Amiee ThompsonPetition StarterPediatric Cancer Mom Mom of 4 Kids deserve better.

Petition Updates